Biochemical marker of bone turnover in renal failure;Marqueurs biologiques osseux dans I'insuffisance rénale

Annales de Biologie Clinique

Volumn 59, Issue 3, 2001, Pages 313-316

  Urena P ^a  

^a Service de néphrologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM; COLECALCIFEROL; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; SOMATOMEDIN C; BIOLOGICAL MARKER; VITAMIN D;

BONE DISEASE; BONE METABOLISM; BONE REMODELING; BONE SCINTISCANNING; BONE TURNOVER; HUMAN; KIDNEY FAILURE; OSTEOLYSIS; REVIEW; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; PATHOPHYSIOLOGY;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE REMODELING; BONE RESORPTION; HUMANS; KIDNEY FAILURE, CHRONIC; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D;

EID: 0034972322     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Increased bone strontium levels in hemodialysis patients with osteomalacia
2. Bone histomorphometry in hemodialysed patients
3. New concepts in renal osteodystrophy
4. Circulating biochemical markers of bone remodeling in uremic patients
5. Intact parathyroid hormone overestimates the presence and the severity of parathyroid osseous abnormalities in uremia
6. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values
7. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragment: Implication for PTH measurements in renal failure
8. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in haemodialysis patients
9. Plasma total versus bone alkaline phosphatase as marker of bone turnover in hemodialysis patients
10. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
11. Low serum levels of alkaline phosphatase of bone origin: A good marker of adynamic bone disease in haemodialysis patients
12. High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population
13. Calcitriol may directly suppress bone turnover
14. Évaluation de la phosphatase alcaline osseuse sérique au cours des affections métaboliques de l'os
15. A new assay method that detects only intact osteocalcin. Two-step non-invasive diagnosis to predict adynamic bone disease in haemodialysed patients
16. Les marqueurs osseux dans l'insuffisance rénale